Related Experiment Video

Updated: Jul 23, 2026

A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
09:59

A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia

Published on: September 16, 2017

14.1K

Estimation of prognosis in patients after decompressive craniectomy after malignant hemispheric infarction:

Robert Chrenko, Svorad Trnovec, Martin Hanko

    Bratislavske Lekarske Listy
    |April 16, 2024
    PubMed

    Insights

    This study developed a new scoring scale to predict outcomes for patients undergoing decompressive hemicraniectomy after malignant hemispheric infarction. The scale uses age, consciousness, and infarct size to guide surgical decisions.

    Area of Science:

    • Neurosurgery
    • Neurology
    • Critical Care Medicine

    Background:

    • Decompressive hemicraniectomy is used for malignant hemispheric infarction, but patient selection, especially for older individuals or those with severe symptoms, remains challenging.
    • Current criteria for surgical indication in malignant brain infarction do not fully address prognostic uncertainties in older patients or those with significant neurological deficits.

    Purpose of the Study:

    • To develop a multifactorial scoring scale to optimize prognosis assessment in patients undergoing decompressive hemicraniectomy for malignant stroke.
    • To improve decision-making regarding surgical indications by providing a data-driven prognostic tool.

    Main Methods:

    • Prospective observational study with a one-year follow-up of patients treated with decompressive hemicraniectomy for malignant brain infarction.
    • Assessment of clinical and imaging data, with the Barthel index used as the primary outcome measure.
    • Statistical analysis to identify variables associated with clinical outcomes and development of a predictive scoring system.

    Main Results:

    • Patient age, preoperative consciousness level, midline shift, and infarct volume were significantly associated with the postoperative Barthel index.
    • A multifactorial prognostic scoring system was developed, achieving an Area Under the Curve (AUC) of 0.74 (95% CI 0.58–0.89, p=0.01) in ROC analysis.
    • The scale effectively distinguishes between favorable and unfavorable outcomes.

    Conclusions:

    • Prognostic prediction after decompressive hemicraniectomy should integrate multiple clinical and imaging variables.
    • The developed scoring scale aids in decision-making to estimate the potential benefits of decompressive craniectomy in malignant brain infarction patients.
    • This tool can enhance the selection of appropriate candidates for hemicraniectomy, particularly in complex cases.
    Abstract

    More Related Videos

    A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury06:18

    A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury

    Published on: March 26, 2019

    9.0K
    Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions07:30

    Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

    Published on: April 23, 2021

    3.0K

    Related Concept Videos

    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

    Cardiomyopathy VII: Pre and Post Operative Nursing Management

    Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...